Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two Medical Sciences researchers are amongst the seven successful applicants to have been chosen as the 2019-20 cohort of Public Engagement with Research (PER) Leaders.

Dr Katharine Owen (OCDEM, Radcliffe Department of Medicine) and Dr Sean Elias (Jenner InstituteNuffield Department of Medicine) are two of only seven researchers to be chosen in the 2019-20 cohort of Public Engagement with Research (PER) leaders at the University of Oxford. 

The PER Leadership scheme is for academics to take on a leadership role in a culture change project for their departments and faculties to enhance support for PER. The scheme is targeted at those who have a strong interest in PER, who want the opportunity to demonstrate their leadership skills within an academic environment and to explore new ways of working through facilitating change. The seven winners will each receive £5,000 to initiate PER-focused initiatives within their departments, and will participate in training from a variety of internal and external PER and leadership professionals throughout the coming year.

Dr Katharine Owen is a consultant endocrinologist and academic working in OCDEM (with an interest in rare monogenic forms of diabetes and young adult diabetes. She has organised events to showcase the research done at OCDEM and RDM, as well as to mark World Diabetes Day (pictured are schoolchildren recreating the 'blue ring' symbol for World Diabetes day around the Radcliffe Infirmary Fountain,  the 2018 event Dr Owen organised). Read more here.

Dr Sean Elias is Principal Investigator at the Jenner Institute studying non-typhoidal Salmonella (NTS). Since May 2016 he has been working with Professor Calman MacLennan on invasive NTS disease in Ghana and Burkina Faso and has more recently run his own clinical studies in the UK and Kenya looking at non-invasive sampling methods for gathering immunological data. As an immunologist he is interested in human antibody and cellular responses to NTS pathogens and how greater understanding of this can aid in future vaccine development. Since 2018 he has run his own public engagement initiative funded through the University Public Engagement with Research Seed Fund program: Oxford University Board Games & Public Engagement, which focuses on using board games to engage the public, using both commercial games and novel games designed by researchers at the University of Oxford.

 

Read more about the awards 

Similar stories

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.